COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)		3 Months Ended
	Dec. 26, 2017	Mar. 31, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
License agreement description		Jay Pharma, Tikkun Olam LLC (“TO LLC”) and Tikkun Olam Hemp LLC (“TOH”) entered into a license agreement dated on January 10, 2020, pursuant to which Jay Pharma would acquire certain in-licensed and owned intellectual property rights related to the cannabis products in the United States (presently excluding the state of New York) from TO LLC and TOH, each of which is an affiliate of TO Holdings, in exchange for royalty payments of (i) four percent (4.0%) of net sales of OTC cancer products made via consumer channels; (ii) five percent (5.0%) of net sales of beauty products made via consumer channels; and (iii) three percent (3.0%) of net sales of OTC cancer products made via professional channels, along with a minimum net royalty payment starting in January 1, 2022 and progressively increasing up to a cap of $400,000 maximum each year for the first 10 years, then $600,000 maximum each year for the next 5 years, and an annual maximum cap of $750,000 each year thereafter during the term of the agreement
Vogal Nathan Purchase Agreement [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Royalties percentage	2.00%
Payments for royalties	$ 20,000,000
Vogal Nathan Purchase Agreement [Member] | One Time Milestone [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Long-term purchase commitment, amount	200,000
Vogal Nathan Purchase Agreement [Member] | Additional Milestone [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Long-term purchase commitment, amount	$ 300,000